Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.
|Recent Press Releases||More >>|
Flex Pharma Reports Second Quarter 2017 Financial Results
Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US
Flex Pharma Names William McVicar President and Chief Executive Officer
|Upcoming Events||More >>|
|There are currently no events scheduled.|
|Data Provided by Thomson Reuters|